PTX 2.33% 4.2¢ prescient therapeutics limited

Totally agree malmanu, considering ovarian & AML trials have...

  1. 114 Posts.
    lightbulb Created with Sketch. 34
    Totally agree malmanu, considering ovarian & AML trials have been given the green light to proceed with slight change in protocol, one would think similar logic will apply with the phase 2 breast trial. With all that is going on in current ptx200 trials plus kicking off ptx100 in heamotology niche, I'm anticipating an SP re-rate to Edison valuation of 0.29 + is very likely in 2018! See you at the AGM...
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
-0.001(2.33%)
Mkt cap ! $33.82M
Open High Low Value Volume
4.4¢ 4.4¢ 4.2¢ $8.214K 193.5K

Buyers (Bids)

No. Vol. Price($)
2 32561 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 5169 1
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.